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ABSTRACT
Introduction: Motor slowness (bradykinesia) is a core feature of Parkinson’s disease (PD).
It is often assumed that patients show mental slowness (bradyphrenia) as well; how-
ever, evidence for this is debated. The aims of this study were to determine whether PD
patients show mental slowness apart from motor slowness and, if this is the case, to
what extent this affects their performance on neuropsychological tests of attention,
memory, and executive functions (EF). Method: Fifty-five nondemented PD patients and
65 healthy controls were assessed with a simple information-processing task in which
reaction and motor times could be separated. In addition, all patients and a second
control group (N = 138) were assessed with neuropsychological tests of attention,
memory, and EF. Results: While PD patients showed significantly longer reaction times
than healthy controls, their motor times were not significantly longer. Reaction and
motor times were only moderately correlated and were not related to clinical measures
of disease severity. PD patients performed significantly worse on tests of attention and
EF, and for the majority of neuropsychological tests 11–51% of the patients showed a
clinically impaired performance. Reaction times did not, however, predict patients’ test
performance, while motor times were found to have a significant negative influence on
tests of attention. Conclusions: PD patients show mental slowness, which can be
separated from motor slowness. Neuropsychological test performance is not influenced
by mental slowness; however, motor slowness can have a negative impact. When
interpreting neuropsychological test performance of PD patients in clinical practice,
motor slowness needs to be taken into account.
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The diagnosis of Parkinson’s disease (PD) is based
on the presence of motor symptoms, with brady-
kinesia being the single most important diagnostic
sign (Wolters, van Laar, & Berendse, 2007).
Bradykinesia manifests itself as visible slowness
and diminished amplitude of movement (Hughes,
Daniel, Kilford, & Lees, 1992). Slowness is, how-
ever, assumed to be associated not only with motor
behavior in PD, but with mental information pro-
cessing as well. This mental equivalent of bradyki-
nesia is called bradyphrenia or mental slowness
(Revonsuo, Portin, Koivikko, Rinne, & Rinne,
1993; Wolters et al., 2007).
The presence of mental slowness in PD patients
is, however, a subject of discussion. Several studies
found evidence for the presence of mental slowness
(Berry, Nicolson, Foster, Behrmann, & Sagar, 1999;
Gauntlett-Gilbert & Brown, 1998; Hsieh, Chen,
Wang, & Lai, 2008; Muslimovic, Post, Speelman, &
Schmand, 2005; Revonsuo et al., 1993; Sawamoto,
Honda, Hanakawa, Fukuyama, & Shibasaki, 2002),
whereas other studies could not demonstrate mental
slowness in PD (Duncombe, Bradshaw, Iansek, &
Phillips, 1994; Helscher & Pinter, 1993; Phillips
et al., 1999). A possible explanation for this lack of
consensus is that a broad variety of measures is used
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to assess speed of information processing as an
indication of mental slowness. Some measures also
include the measurement of higher order cognitive
functions such as memory or executive functions
(EF; Albinet, Boucard, Bouquet, & Audiffren, 2012).
Furthermore, previously many studies aimed to
assess speed of information processing as an indica-
tion of mental slowness, but used measures that also
included a manual motor response. However, in
terms of neural networks, a global distinction can
be made between the central processes of planning,
preparing, and initiating a motor response and the
physical execution of that manual motor response
(i.e., peripheral nervous system). The central pro-
cesses primarily involve activity in the prefrontal
cortex, the supplementary, premotor cortex and
the primary motor cortex, whereas the actual
motor response involves primarily muscle activity
in the arm and hand (Wolters et al., 2007). Since
peripheral motor dysfunction is common in certain
patient populations (e.g., patients with dystonia,
Huntington’s disease, and PD), it is crucial to dis-
tinguish between the assessment of speed of mental
information processing and motor speed
(Salthouse, 1994, 1996) when determining actual
mental slowness. For this purpose, information-
processing tasks that allow differentiation between
reaction time (i.e., measure of information-proces-
sing speed as an indication of mental slowness) and
motor time are preferred to more standard neurop-
sychological tests that include manual or verbal
motor activity (e.g., Trail Making Test or Stroop),
which do not allow disentanglement of both com-
ponents. To our knowledge, such tasks have not yet
been applied to study the concepts of mental and
motor slowness in patients with PD. Therefore, our
main objective was to examine whether mental and
motor slowness could be measured separately and
consequently whether these can be differentiated
from each other in PD patients using such a para-
digm. Based on the assumption that bradykinesia
and bradyphrenia are characteristic clinical signs of
PD, we expect this to be demonstrated by longer
motor as well as longer reaction times of PD patients
than of healthy controls. On the other hand, since
we assume bradykinesia and bradyphrenia to be
distinguishable concepts, it is hypothesized that
motor and reaction times can be correlated, but do
not show a one-to-one relationship.
Furthermore, if PD patients exhibit mental slow-
ness, the second aim is to determine to what extent
this mental slowness influences the performance on
neuropsychological tests. Neuropsychological tests
are frequently used for the assessment of cognition
in PD patients and have demonstrated that cognitive
impairments, especially within the domains of atten-
tion, memory, and EF, are common in this group
(Elgh et al., 2009; Muslimovic et al., 2005). However,
the majority of tests contain either a direct (outcome
is measured as time of completion, e.g., Trail
Making Test) or an indirect (presentation of stimuli
at a fixed pace, e.g., Rey Auditory Verbal Learning
Test) speed component. It seems therefore likely
that impaired performances of PD patients on
such tests can, at least partially, be explained by
their mental slowness. So far, only a small number
of studies investigated the influence of mental slow-
ness on cognitive test performance. Both Albinet
et al. (2012) and Salthouse (1992) showed that men-
tal slowness (partially) accounted for healthy parti-
cipants’ age-related differences in cognitive test
performance. Moreover, differences on tests for
focused and divided attention between patients
with traumatic brain injury and healthy controls
disappeared when scores were controlled for mental
slowness (Spikman, van Zomeren, & Deelman,
1996). Only one study investigated the role of men-
tal slowness in PD patients and concluded that
mental slowness was not related to executive func-
tioning (Liozidou, Potagas, Papageorgiou, &
Zalonis, 2012). Knowledge about the influence of
slowness on neuropsychological tests performance
is crucial in clinical practice, since it has to be
determined whether impaired test performance can
be interpreted as deficits of memory, attention, and
EF, or has to be attributed to slowness of informa-
tion processing. Since most neuropsychological tests
require also manual or verbal motor activity, the
effect of motor slowness on neuropsychological
test performance is examined as a subquestion.
Finally, it is determined to what extent motor slow-
ness, as measured with an information-processing
task, and motor symptoms and disease severity, as
measured with more clinical measures (Unified
Parkinson’s Disease Rating Scale motor section,




Fifty-five patients with idiopathic PD who were
diagnosed according to the UK Parkinson’s
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Disease Brain Bank Criteria were included.
Exclusion criteria were dementia (i.e., Scales for
Outcomes in Parkinson’s Disease–Cognition
Scale, SCOPA–COG, score ≤17; Verbaan et al.,
2011) and other severe neurological and psychia-
tric comorbid conditions. Patients were recruited
at the Department of Neurology of three medical
centers in The Netherlands. Neuropsychological
assessment was conducted while patients were on
their regular dopaminergic medication and in the
on phase. Four patients were not on dopaminergic
therapy, and two patients did not report their
current medication use. Furthermore, five patients
underwent deep brain stimulation (targets: subtha-
lamic nucleus, N = 3; globus pallidus, N = 1;
thalamus, N = 1), which was performed more
than one year prior to study inclusion. A levodopa
equivalent daily dose (LEDD) was calculated for all
patients who were on dopaminergic medication
(Esselink et al., 2004). The UPDRS–III and the
H&Y scale were used to assess disease severity.
Patients in H&Y Stages 4 and 5 were not included
in this study. The study was approved by the
medical ethical committee and was conducted in
accordance with the declaration of Helsinki. All
patients gave written informed consent.
In addition, data of two healthy control groups
were used that came from several sources. Exclusion
criteria were major neurological diseases and/or psy-
chiatric disorders. One control group (HC1: N= 65)
was assessed with the simple information-processing
task (see below for a detailed description of this task);
data were provided by Schuhfried GmbH test com-
pany, Vienna, Austria. PD patients’ performances on
neuropsychological tests were compared to data of a
second group of healthy controls (HC2), who were
assessed with all neuropsychological tests that were
used in the present study, except for the simple
information-processing task. HC2 was composed
out of healthy controls that were included in our
previous studies. For tests of attention, memory,
and EF the number of controls with available data
ranged from N = 77 (Stroop) to N = 136 (Zoo Map).
For the Rey Auditory Verbal Learning Test
(RAVLT), data of 32 controls were available.
Table 1 shows descriptive variables and disease char-
acteristics of PD patients and both healthy control
groups. Level of education of all participants was
classified on a 5-point scale ranging from (1) uncom-
pleted or special education: < 9 years of education, to
(5) completed university (of applied sciences).
Neuropsychological assessment
Speed of information processing
The simple information-processing task (S1 con-
dition) of the Vienna Test System (Prieler, 2008)
was used to measure reaction time and motor
time separately. During the task, the partici-
pants’ dominant index finger rested on a key
(rest key). A black circle was constantly present
in the middle of the lower half of the screen, and
as soon as this circle turned yellow, participants
were instructed to lift their index finger and to
press the response key as fast as possible. The
distance between the rest key and the response
key was 5.5 cm. The interstimulus interval ran-
ged between 1.5 to 6.5 s, and the duration of the
presentation of the yellow circle was 1 second.
The task consisted of five practice trials and 28
test trials. For each participant, two scores were
calculated: (a) mean reaction time (RT)—that is,
the mean time between the appearance of the
target stimulus and lifting the dominant index
finger over all correctly completed trials—and
(b) mean motor time (MT)—the mean time
Table 1. Descriptive and disease characteristics of PD patients and healthy control groups.
PD HC1 HC2
Participant characteristics Mean (SD) Range Mean (SD) Range Mean (SD) Range
Age in years 61.0 (9.5) 42–79 63.1 (5.1) 55–80 59.0 (7.6) 38–87
Education in years (Med; IQR) 4.0 (1.0) 2–5 3.0 (1.0) 2–5 3.0 (1.0) 2–5
Sex
Male n (%) 36 (65.5) 41 (63.1) 72 (52.2)
Female n (%) 19 (34.5) 24 (36.9) 6 (47.8)
UPDRS–III 21.2 (8.2) 8–46 — —
H&Y (Med; IQR) 2.5 (0.5) 1–3 — —
LEDD 731.3 (457.8) 0–2080.0 — —
SCOPA–COG 28.8 (4.4) 19–37 — —
Note. Educational level was classified on a 5-point scale; 1 = unfinished or special education, <9 years of education, 5 = Bachelor or Master’s
degree. PD = Parkinson’s disease; HC = healthy controls; Med = median; IQR = interquartile range; UPDRS–III = Unified Parkinson’s Disease
Rating Scale Part III, motor section, range = 0–108 maximum; H&Y= Hoehn and Yahr scale, range = 0–5 maximum; LEDD = levodopa
equivalent daily dose; SCOPA–COG = Scales for Outcomes in Parkinson’s Disease–Cognition, range = 0–43 max.
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between lifting the dominant index finger and
pressing the response key over all correctly com-
pleted trials. Both reaction time and motor time
were measured in milliseconds.
Neuropsychological tests of attention, memory,
and executive functions
The Trail Making Test Part A (TMT; in seconds;
Reitan, 1958) and the Stroop Word Card (in sec-
onds; Stroop, 1935) were used to assess attention.
Short-term verbal memory was measured with the
Digit Span Forward (total score; Wechsler, 1987).
The Rey Auditory Verbal Learning Test (Dutch
version; RAVLT; Deelman, Brouwer, van
Zomeren, & Saan, 1980) is a verbal memory test
that was used to measure immediate recall (IR;
max. score = 75) and delayed recall (DR; max.
score = 15) of unrelated verbal information. EF
were assessed with the TMT B/A ratio (Reitan,
1958) and Visual Elevator (Test of Everyday
Attention; TEA; max. score= 10; Robertson,
Ward, Ridgeway, & Nimmo-Smith,1994), Stroop
Color–Word/Color card ratio (Stroop, 1935), and
the subtest Zoo Map (total score) of the
Behavioural Assessment of the Dysexecutive
Syndrome (BADS; Wilson, Alderman, Burgess,
Emslie, & Evans, 1996).
Statistical analyses
IBM Statistical Package for the Social Sciences
Version 22 was used for data analysis. Analyses
of covariance (ANCOVAs) with age, gender, and
level of education included as covariates were used
to compare the performances of PD patients and
healthy controls on the simple information-proces-
sing task and neuropsychological tests (Tables 2
and 3). For statistical analysis an alpha of .05 was
applied. In case of multiple comparisons (Table 3)
a Bonferroni-corrected alpha was used per cogni-
tive domain. Furthermore, effect sizes for group
differences were calculated (Cohen’s d).
Correlations were calculated to determine the asso-
ciations between the RT, MT, UPDRS, neuropsy-
chological tests (Pearson’s r), and H&Y
(Spearman’s rs). Performances of PD patients and
controls on the simple information-processing task
and other neuropsychological tests were also ana-
lyzed from a clinical perspective—that is, perfor-
mances on tests were compared to representative
normative data as provided by the test developers.
Performances that fell within the lowest 10% of the
normative samples were considered as being
impaired (Lezak, Howieson, Loring, Hannay, &
Fischer, 2004). Finally, hierarchical linear regres-
sion analyses (method: enter) were used to study
the influence of speed of information processing
Table 2. Performances of PD patients and healthy controls on the simple information-processing task of the Vienna Test
System.
PD HC1 ANCOVA Covariates ES
Simple information-processing task Mean (SD) Mean (SD) F (p) Age Sex Edu d
Motor time 232.73 (78.64) 218.35 (72.19) 1.97 (.163) ns ns ns 0.19
Reaction time 363.53 (84.67) 316.34 (75.93) 10.10 (.002)* ns ns ns 0.60
Note. PD = Parkinson’s disease; HC = healthy controls; ANCOVA = analysis of covariance; ES = effect size; Edu = education. Times in ms.
*p < .01.
Table 3. Performances of PD patients and healthy controls on tests of cognition.
PD Covariates ES




F (p) Age Sex Edu d
Attention TMT A 25.5 (14) 43.18 (13.19) 33.34 (9.40) 24.38 (<.001)* * ns ns 0.90
Stroop Word Card 50.9 (28) 50.96 (9.66) 47.16 (7.68) 5.02 (.027)* * ns ns 0.44
Memory Digit span forward 3.6 (2) 8.73 (1.65) 8.82 (1.69) 0.06 (.815) * ns ns 0.05
RAVLT IR 35.2 (19) 38.35 (11.25) 38.84 (10.36) 0.53 (.470) * * * 0.04
RAVLT DR 11.1 (6) 7.85 (3.14) 7.38 (3.38) 0.40 (.528) ns * * 0.15
EF TMT ratio 20.0 (11) 2.48 (0.93) 2.17 (0.53) 4.64 (.033) * ns ns 0.44
Stroop ratio 3.6 (2) 1.64 (0.28) 1.54 (0.18) 4.73 (.032) * ns * 0.41
Visual Elevator total score 18.2(10) 7.83 (2.28) 8.44 (1.65) 2.42 (.122) * ns ns 0.32
Zoo Map total score 27.3 (22) 8.29 (5.68) 10.84 (4.71) 10.49 (.001)* * ns * 0.51
Note. PD = Parkinson’s disease; HC = healthy controls; ANCOVA = analysis of covariance; ES = effect size; Edu = education; EF = executive
functions; TMT = Trail Making Test; RAVLT = Rey Auditory Verbal Learning Test; IR = immediate recall; DR = delayed recall; TMT ratio = TMT B/
TMT A; Stroop ratio = Color–Word/Color card. ANCOVA was conducted for the RAVLT IR and DR with level of education included as a covariate.
*Significant p < Bonferroni-corrected alpha.
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on patients’ performances on each neuropsycholo-
gical test separately. The assumptions for regres-
sion analyses were met. MT (Block 1) and RT
(Block 2) were respectively included as indepen-
dent variables into each model. Scores on tests of
attention (TMT A and Stroop Word Card), mem-
ory (Digit Span Forward and RAVLT), and EF
(TMT B/A, Stroop ratio, Visual Elevator and Zoo
Map) were dependent variables.
Results
Demographic data
No differences were found between HC1 and PD
patients with regard to age (t = –1.46, p = .149),
gender (χ2 = 0.07, p = .787), and level of education
(Mann–Whitney U = 1617.50, p = .342). Overall,
there were also no differences between PD patients
and HC2 in age (t = 1.39, p = .167), gender (χ2 =
2.81, p = .093), and level of education (Mann–
Whitney U = 3232.00, p = .086). The RAVLT
subgroup of HC2 (N = 32) did not differ from
PD patients with regard to age (t = –0.15, p =
.878) and gender (χ2 = 2.01, p = .156). However,
level of education was significantly different
between this subgroup and PD patients (Mann–
Whitney U = 585.50, p = .006). Because the results
show some trend-level differences between patients
and controls, and since it is known that age, gen-
der, and level of education can be of influence on
cognitive test performance, these demographic
variables were included as covariates in further
analyses. Demographic data are presented in
Table 1.
Simple information-processing task and
neuropsychological test performance
In comparison to healthy controls, PD patients
showed a significantly slower RT (medium effect
size, see Table 2). No differences were found
between groups with regard to MT. From a clinical
perspective, the simple information-processing
task revealed clinically impaired mental slowness
in 11% of PD patients and clinically impaired
motor slowness in 7% of PD patients (performance
≤ lowest 10% of normative sample). In the healthy
control group, 5% of controls showed clinically
impaired mental slowness and 6% impaired
motor slowness. The percentage of impairments
did not significantly differ between groups for
both mental and motor slowness (RT: χ2 = 1.70,
p = .192; MT: χ2 = 0.38, p = .536).
A significant but moderate correlation was
found between the RT and MT of the simple
information-processing task (PD patients: r = .40,
p = .003; controls: r = .41, p = .001). In addition, no
significant associations were found between the
scores on the UPDRS–III and H&Y and the RT
and MT (RT and H&Y: rs = .11, p = .465; RT and
UPDRS: r = .17, p = .227; MT and H&Y: rs = .09, p
= .553; MT and UPDRS: r = .23, p = .108).
Table 3 presents the average performance of PD
patients and healthy controls on tests of attention,
memory, and EF. PD patients performed signifi-
cantly worse than healthy controls on tests of
attention and on the Zoo Map. Groups did not
differ with regard to the performances on other
tests of EF and memory. However, for six out of
nine tests, 11 to 51% of PD patients’ test scores
were considered as clinically impaired.
In Table 4 the univariate associations between
MT, RT, and neuropsychological test performance
of PD patients are presented. A significant correla-
tion was found between MT and the TMT A and
Stroop ratio. RT also showed a significant correla-
tion with the Stroop ratio. Consequently, hierarch-
ical regression analyses were conducted to study
whether neuropsychological test scores of PD
patients can be predicted from MT and RT. MT
and RT were separately included (i.e., MT = Block
1, RT = Block 2) in the regression models to
determine their individual contribution to the
model. Table 5 shows that MT alone appeared to
be a significant predictor of performance on the
TMT A [R2 = .09, F(1, 54) = 5.53, p = .022].
However, when RT was included the model was
Table 4. Univariate Pearson’s correlations between MT, RT,
and neuropsychological tests in PD patients.
Domain Cognitive measure MT RT
Attention TMT A .31* .16
Stroop Word Card .25 .26
Memory Digit Span Forward –.20 –.02
RAVLT IR –.25 –.18
RAVLT DR –.13 –.10
EF TMT ratio .16 .07
Stroop ratio .41* .36**
Visual Elevator total score –.10 –.21
Zoo Map total score –.17 –.05
Note. PD = Parkinson’s disease; TMT = Trail Making Test; RAVLT = Rey
Auditory Verbal Learning Test; IR = immediate recall; DR = delayed
recall; TMT ratio = TMT B/TMT A; Stroop ratio = Color–Word/Color
card; MT = motor time; RT = reaction time; EF = executive
functions.
*p < .05. **p < .01.
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no longer significant [R2 = .10, F(2, 54) = 2.77, p =
.072]. Furthermore, a different pattern was found
for the complete model of the Stroop Color–
Word/Color card ratio. The complete model
(including MT and RT) explained a significant
percentage of variance in the Stroop Color–
Word/Color card ratio [R2 = .22, F(2, 54) = 7.10,
p = .002]; however, only MT was found to con-
tribute significantly to the model (see Table 5). For
the other neuropsychological tests, neither the
combination of MT and RT nor MT or RT sepa-
rately were significant predictors of PD patients’
performances; the results of complete models were
as follows: attention [Stroop Word Card: R2 = .09,
F(2, 54) = 2.67, p = .079], memory [Digit Span
Forward: R2 = .05, F(2, 54) = 1.24, p = .298;
RAVLT IR: R2 = .07, F(2, 54) = 2.00, p = .146;
RAVLT DR: R2 = .02, F(2, 54) = 0.52, p = .597],
and EF [TMT B/A ratio: R2 = .02, F(2, 54) = 0.64, p
= .532; Visual Elevator: R2 = .04, F(2, 51) = 1.12, p
= .335; Zoo Map total score: R2 = .03, F(2, 54) =
0.82, p = .444].
Discussion
To our knowledge, this is the first study that mea-
sures RT and MT separately in order to determine
whether mental slowness can be differentiated
from motor slowness in patients with Parkinson’s
disease. PD patients showed on average a signifi-
cantly longer RT on a simple information-proces-
sing task than healthy controls. Surprisingly, PD
patients’ MT’s were not significantly slower than
healthy controls. This is remarkable since bradyki-
nesia is a core feature of PD. These findings indi-
cate that mental slowness can be present in PD
patients in the absence of motor slowness and
strengthen findings of previous studies that
demonstrated mental slowness in PD even though
these studies did not use tasks that allowed the
differentiation of mental and motor slowness
(Berry et al., 1999; Gauntlett-Gilbert & Brown,
1998; Hsieh et al., 2008; Muslimovic et al., 2005;
Revonsuo et al., 1993; Sawamoto et al., 2002).
The finding that mental and motor slowness are
distinctive constructs was also substantiated by the
moderate correlations between RT and MT in both
patients and controls, which indicates that RT and
MT only share a relatively small amount of var-
iance (i.e., 16%). Interestingly, clinical ratings of
motor symptoms and disease severity (i.e., scores
on UPDRS–III and H&Y scale) were related
neither to RT nor to MT. A possible explanation
for this finding is that standard clinical measures
of motor symptoms in PD assess motor slowness
(i.e., bradykinesia) in a different way from reaction
time paradigms. The unexpected finding that
patients did not show significantly slower MTs
than healthy controls strengthens this interpreta-
tion. The UPDRS, for example, assesses motor
slowness with several items that do not only ask
the observer to evaluate the speed of a specific
motor action, but also ask them to evaluate the
amplitude, hesitations, and halts of the action per
side of the body. Even though the bradykinesia
subscale of the UPDRS is a valid measure of
motor slowness (Buck, Wilson, Seeberger,
Conner, & Castelli-Haley, 2011), to our knowledge
the relation with reaction time paradigms has not
been studied so far and may represent an interest-
ing subject for future research.
The second aim of the current study was to
determine the influence of mental slowness on
neuropsychological test performance of PD
patients. This is relevant, because the majority of
neuropsychological tests include a speed compo-
nent (i.e., in the outcome measure or paced pre-
sentation of stimuli). Hence, PD patients’
performances on these tests may be negatively
influenced by disease-related mental slowness,
which may have consequences for the interpreta-
tion of test results in clinical practice. The group of
PD patients that was included in the present study
showed a profile of cognitive impairments that was
Table 5. Predictors of PD patients’ performance on tests of attention and EF based on hierarchical linear regression
analysis.
Domain Cognitive measure Variable R2 R2 change B β t p
Attention TMT A Constant 31.187 5.80 <.001**
Motor time .09 0.052 0.31 2.35 .022*
EF Stroop ratio Constant 1.093 6.88 <.001**
Motor time .17 0.001 0.32 2.38 .021*
Reaction time .22 .05 0.001 0.23 1.74 .089
Note. PD = Parkinson’s disease; EF = executive functions; TMT = Trail Making Test. Regression analysis, method: enter.
*p < .05. **p < .001.
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY 849
consistent with previous studies (Koerts, Tucha,
Lange, & Tucha, 2013; Muslimovic et al., 2005;
Watson & Leverenz, 2010), indicating that a repre-
sentative group of PD patients was included.
Results of regression analyses showed that RT as
an indication of mental slowness did not predict
PD patients’ performances on any of the neurop-
sychological tests of attention, memory, and EF,
which is in line with the findings of Liozidou et al.
(2012). MT, on the other hand, was found to be a
significant predictor of PD patients’ performance
on TMT A and the Stroop Color–Word/Color card
ratio. With regard to the TMT A this is not sur-
prising, since this paper-and-pencil test involves
manual motor activity because it requires patients
to search and connect succeeding numbers as fast
as possible by drawing a line. Regarding the Stroop
Color–Word/Color card ratio it seems that even
though we used the ratio score that implies to
control for the speed component (measured with
the Color card), this measure still reflects motor
behavior—that is, reading words out loud as fast as
possible.
The current study has a few limitations that
need to be mentioned. First, the heterogeneity of
the patient group with regard to treatment (dopa-
minergic treatment N = 44; nondopaminergic
treatment/treatment unknown N= 6; deep brain
stimulation, DBS, N = 5) is a limitation, since
dopaminergic treatment and DBS can have posi-
tive as well as negative effects on cognition
(Cools, 2006; Cools, Barker, Sahakian, &
Robbins, 2001, 2003). When comparing, however,
the results on descriptive measures and the RT
and MT between patients on dopaminergic treat-
ment and patients who received DBS or of whom
the treatment strategies were unknown, no differ-
ences were found (data not shown). Furthermore,
when analyzing the MTs, we did not control for
possible minor on–off fluctuations. Since there
were no significant differences between patients
and controls regarding the MTs of the simple
information-processing task, we assume that the
minor on–off fluctuations did not negatively
influence test performance. Another limitation is
the use of the UPDRS–III total score instead of a
sum score of the individual bradykinesia items.
Since the total score also includes the evaluations
of rigidity and tremor, it is possible that the
association between the UPDRS–III and RT and
MT would have been different when these items
were excluded. Also, the use of normative data,
without adjustments for age, gender, and educa-
tion, when determining the percentage of
impaired RTs and MTs in PD patients and
healthy controls can be considered a limitation.
However, when, for example, an age-related norm
group was used, the size of the normative sample
would have been substantially smaller. Therefore
the use of a general norm group was preferred.
Since the percentage of impaired performances
on the simple information-processing task did
not significantly differ between patients and con-
trols, the sensitivity of the paradigm appears to be
insufficient and must be considered a limitation.
A final limitation is that for PD patients the exact
disease duration was not reported in this study.
The possible influence of disease duration on test
performance could therefore not be analyzed.
In conclusion, PD patients show mental slow-
ness that can be separated from slowness of
movement. However, this mental slowness did
not have an influence on the performances of
PD patients on various neuropsychological tests
for attention, memory, and EF. Interestingly,
patients showed no motor slowness on the simple
information-processing task. Also, their MTs
were not related to clinical measures of disease
severity (including bradykinesia), indicating that
both measures assess motor slowness in a differ-
ent way. MTs did, however, determine patients’
performance on two test measures of which the
outcome was measured in terms of speed. We
tentatively conclude that these findings indicate
that mental slowness is not a substantial factor
that needs to be taken into account when inter-
preting results of PD patients on these neuropsy-
chological tests. PD patients’ motor speed, on the
other hand, can be of influence on test perfor-
mances and needs to be taken into consideration
in clinical practice.
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